Assess whether management can run this without the founder after a customer

SITUATION A customer who just sent a non-renewal put regulatory-approval critical-path calendar in front of customer-contract risk reviewer in a public acquirer facing HSR and sector regulators. This M&A Due Diligence / People and Contracts close is management can run this from regulatory-approval critical-path calendar, and the live options are Proceed, Reprice, Walk.

DECISION Customer-contract risk reviewer in a public acquirer facing HSR and sector regulators must choose Proceed / Reprice / Walk / Hold using regulatory-approval critical-path calendar after a customer who just sent a non-renewal.

HYPOTHESES TO TEST 1. Regulatory-approval critical-path calendar reads as Proceed once a customer who just sent a non-renewal is lined up to the same M&A Due Diligence population. 2. Regulatory-approval critical-path calendar is closer to Reprice after a customer who just sent a non-renewal; Proceed would over-claim this People and Contracts extract. 3. Walk is still live in regulatory-approval critical-path calendar for customer-contract risk reviewer in a public acquirer facing HSR and sector regulators. 4. Regulatory-approval critical-path calendar is missing the fact customer-contract risk reviewer needs after a customer who just sent a non-renewal; stop this M&A Due Diligence close.

ANALYSIS REQUIRED 1. Name the document customer-contract risk reviewer still needs before signing. 2. Test whether a customer who just sent a non-renewal is a diligence gap, a price chip, or a walk-away. 3. Separate a one-off add-back from a recurring earnings issue in regulatory-approval critical-path calendar. 4. For this M&A Due Diligence People and Contracts file, read regulatory-approval critical-path calendar against a customer who just sent a non-renewal and write the one fact that would move management can run this for customer-contract risk reviewer.

RECOMMENDATION Choose Proceed / Reprice / Walk / Hold on this M&A Due Diligence / People and Contracts packet (regulatory-approval critical-path calendar after a customer who just sent a non-renewal). If regulatory-approval critical-path calendar cannot force a M&A Due Diligence label under People and Contracts, stop. Do not invent missing evidence a public acquirer facing HSR and sector regulators does not have.

COMMAND RETURNS - Bottom-line M&A Due Diligence option on management can run this, then the evidence in regulatory-approval critical-path calendar, then the action for customer-contract risk reviewer - Hypothesis scorecard against regulatory-approval critical-path calendar: supported / rejected / untestable - What changes management can run this if a customer who just sent a non-renewal is later withdrawn - Named option among Proceed, Reprice, Walk and the fact that kills the others